ID23360A - PROSE DAN ZAT ANTARA UNTUK SUATU AGONIS RESEPTOR β<3>-ADRENERGIK - Google Patents
PROSE DAN ZAT ANTARA UNTUK SUATU AGONIS RESEPTOR β<3>-ADRENERGIKInfo
- Publication number
- ID23360A ID23360A IDP990951D ID990951D ID23360A ID 23360 A ID23360 A ID 23360A ID P990951 D IDP990951 D ID P990951D ID 990951 D ID990951 D ID 990951D ID 23360 A ID23360 A ID 23360A
- Authority
- ID
- Indonesia
- Prior art keywords
- receptor agonist
- adrenergic
- prose
- substance
- formula
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/06—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom
- C07D213/16—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom containing only one pyridine ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pyridine Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10437598P | 1998-10-15 | 1998-10-15 | |
| US14546099P | 1999-07-23 | 1999-07-23 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ID23360A true ID23360A (id) | 2000-04-20 |
Family
ID=26801476
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IDP990951D ID23360A (id) | 1998-10-15 | 1999-10-13 | PROSE DAN ZAT ANTARA UNTUK SUATU AGONIS RESEPTOR β<3>-ADRENERGIK |
Country Status (15)
| Country | Link |
|---|---|
| US (2) | US6090942A (fr) |
| EP (1) | EP0994105B1 (fr) |
| JP (1) | JP2000128864A (fr) |
| KR (1) | KR20000029108A (fr) |
| CN (1) | CN1256276A (fr) |
| AT (1) | ATE312821T1 (fr) |
| BR (1) | BR9904689A (fr) |
| CA (1) | CA2285914C (fr) |
| DE (1) | DE69928890D1 (fr) |
| HU (1) | HUP9903602A2 (fr) |
| ID (1) | ID23360A (fr) |
| IL (1) | IL132269A0 (fr) |
| PL (1) | PL336053A1 (fr) |
| TR (1) | TR199902565A2 (fr) |
| YU (1) | YU51599A (fr) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6515134B1 (en) * | 1999-02-16 | 2003-02-04 | Kaneka Corporation | Substituted acetylpridine derivatives and process for the preparation of intermediates for optically active beta-3 agonist by the use of the same |
| US6455734B1 (en) * | 2000-08-09 | 2002-09-24 | Magnesium Diagnostics, Inc. | Antagonists of the magnesium binding defect as therapeutic agents and methods for treatment of abnormal physiological states |
| DE60015036T2 (de) | 1999-07-23 | 2006-03-02 | Pfizer Products Inc., Groton | Zwischenprodukte und ein Verfahren zur Herstellung von beta3-Adrenergischer Rezeptor-Agoniste |
| WO2003072573A1 (fr) * | 2002-02-27 | 2003-09-04 | Pfizer Products Inc. | Formes cristallines de (r)-2-(2-(4-oxazol-4-yl-phenoxy)-ethylamino)-1-pyridin-3-yl-ethanol |
| CA2471646A1 (fr) * | 2002-02-27 | 2003-09-04 | Yong Tao | Procedes et intermediaires utiles dans la preparation d'agonistes du recepteur .beta.3-adrenergique |
| US6864268B2 (en) | 2002-02-27 | 2005-03-08 | Pfizer Inc. | β3 adrenergic receptor agonists |
| EP1477167A1 (fr) * | 2003-05-15 | 2004-11-17 | Pfizer Limited | Dérivés de [(2-hydroxy-2-(4-hydroxy-3-hydroxymethylphenyl)-ethylamino)-propyl] phenyl come agonistes de beta2 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0828712A1 (fr) * | 1995-05-10 | 1998-03-18 | Pfizer Inc. | Agonistes du recepteur beta-adrenergique |
| WO1996035671A1 (fr) * | 1995-05-10 | 1996-11-14 | Pfizer Inc. | AGONISTES DU RECEPTEUR β-ADRENERGIQUE |
| GB2305665A (en) * | 1995-09-26 | 1997-04-16 | Merck & Co Inc | Selective ß3 agonists for the treatment of diabetes aand obesity |
| CA2270386C (fr) * | 1996-11-14 | 2004-08-03 | Pfizer Inc. | Procede de preparation de pyridines substituees |
| US6001856A (en) * | 1997-06-13 | 1999-12-14 | Pfizer Inc. | β-adrenergic agonists to reduce a wasting condition |
| EP0920864A1 (fr) * | 1997-12-03 | 1999-06-09 | Pfizer Products Inc. | Thérapie de combinaison comprenant un beta-3 agoniste spécifique et un agent anorexigéne |
-
1999
- 1999-09-29 US US09/408,998 patent/US6090942A/en not_active Expired - Fee Related
- 1999-10-07 IL IL13226999A patent/IL132269A0/xx unknown
- 1999-10-08 YU YU51599A patent/YU51599A/sh unknown
- 1999-10-11 DE DE69928890T patent/DE69928890D1/de not_active Expired - Lifetime
- 1999-10-11 EP EP99307987A patent/EP0994105B1/fr not_active Expired - Lifetime
- 1999-10-11 AT AT99307987T patent/ATE312821T1/de not_active IP Right Cessation
- 1999-10-13 ID IDP990951D patent/ID23360A/id unknown
- 1999-10-13 CA CA002285914A patent/CA2285914C/fr not_active Expired - Fee Related
- 1999-10-14 TR TR1999/02565A patent/TR199902565A2/xx unknown
- 1999-10-14 HU HU9903602A patent/HUP9903602A2/hu unknown
- 1999-10-15 PL PL99336053A patent/PL336053A1/xx not_active Application Discontinuation
- 1999-10-15 JP JP11293733A patent/JP2000128864A/ja active Pending
- 1999-10-15 CN CN99125439A patent/CN1256276A/zh active Pending
- 1999-10-15 BR BR9904689-0A patent/BR9904689A/pt not_active IP Right Cessation
- 1999-10-15 KR KR1019990044778A patent/KR20000029108A/ko not_active Application Discontinuation
-
2000
- 2000-01-20 US US09/488,245 patent/US6124457A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CA2285914A1 (fr) | 2000-04-15 |
| EP0994105A2 (fr) | 2000-04-19 |
| CN1256276A (zh) | 2000-06-14 |
| DE69928890D1 (de) | 2006-01-19 |
| JP2000128864A (ja) | 2000-05-09 |
| ATE312821T1 (de) | 2005-12-15 |
| HUP9903602A2 (en) | 2001-03-28 |
| HU9903602D0 (en) | 1999-12-28 |
| TR199902565A2 (xx) | 2000-05-22 |
| PL336053A1 (en) | 2000-04-25 |
| CA2285914C (fr) | 2003-06-03 |
| IL132269A0 (en) | 2001-03-19 |
| EP0994105A3 (fr) | 2000-05-24 |
| US6124457A (en) | 2000-09-26 |
| US6090942A (en) | 2000-07-18 |
| KR20000029108A (ko) | 2000-05-25 |
| BR9904689A (pt) | 2000-11-14 |
| YU51599A (sh) | 2001-03-07 |
| EP0994105B1 (fr) | 2005-12-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK89595A (da) | Fremgangsmåde til fremstilling af 1-(3-dimethylaminopropyl)-1'-(4-fluorphenyl)-1,3-dihydroisobenzofuran-5-carbonnitril | |
| NZ503912A (en) | Piperidinylaminomethyl trifluoromethyl cyclic ether compounds and their use as substance P antagonists | |
| BR9909739A (pt) | Benzotiadiazóis e derivados | |
| ID23360A (id) | PROSE DAN ZAT ANTARA UNTUK SUATU AGONIS RESEPTOR β<3>-ADRENERGIK | |
| PT93687A (pt) | Processo para a preparacao de antagonistas de serotonina de tetra-hidrobenz,d}indole | |
| FI102174B1 (fi) | Menetelmä 1,2,3,4-tetrahydro- ja 1,2,3,3a,4,8b-heksahydrosyklopent[b]indolijohdannaisten valmistamiseksi | |
| DE60235365D1 (de) | Verfahren zur herstellung von 7-amino-syn-3,5-dihydroxyheptansäurederivaten und zwischenverbindungen diesesverfahrens und deren herestellung | |
| DE60015036D1 (de) | Zwischenprodukte und ein Verfahren zur Herstellung von beta3-Adrenergischer Rezeptor-Agoniste | |
| BR9503845A (pt) | Processo para a preparação de um composto e composto obtido | |
| AR009452A1 (es) | Compuestos de dihalopropeno, los agentes insecticidas/acaricidas que los contienen y los intermediarios de sintesis de dichos compuestos. | |
| DE69724216D1 (de) | Pyridin-Zwischenprodukte, verwendbar zur Herstellung von Beta-adrenergischen Rezeptor-Agonisten | |
| EE03873B1 (et) | Meetod alküüloksüfuranooni amiinderivaatide valmistamiseks, sel meetodil saadud ühendid ja nende kasutamine | |
| NO901176L (no) | Fremgangsmaate for fremstilling av 2,5,6,7-tetranor-4,8-inter-m-fenylen pgi2-derivater. | |
| EA200100299A1 (ru) | Уреидопиперидиновые производные как селективные антагонисты nk3 - рецепторов человека | |
| ES2194361T3 (es) | Procedimiento y compuestos intermedios para la preparacion de un herbicida de triazol. | |
| EG19319A (en) | Process for preparing of glutaric acid derivatives and preparation there of. | |
| YU15500A (sh) | Postupak za dobijanje cikličnih tioamida | |
| DK162188D0 (da) | Fremgangsmaade til fremstilling af pentandionderivater | |
| DE69611136D1 (de) | Verfahren zur Herstellung von optisch aktivem (S)-(-)- und (R)-(+)- Deoxyspergualin und Zwischenprodukte dafür | |
| ATE9219T1 (de) | N-(2-(2-amino-2-phenylethyl)phenyl)-2,2dimethylpropanamid und derivate und ein verfahren zur herstellung derselben. | |
| AR011871A1 (es) | Herbicidas heterociclicos condensados con benceno sustituidos con cicloimida, composiciones que los contienen y metodo de control delcrecimiento indeseado de plantas aplicando los mismos | |
| ECSP972175A (es) | DERIVADOS DE BENZO (g) QUINOLINA |